VC-Backed FORMA Buys SolMap Pharma
Mercury Computer Systems (Nasdaq: MRCY) has sold the assets of SolMap Pharmaceuticals to FORMA Therapeutics, a Cambridge, Mass.-based startup that recently raised around $4 million from the Novartis Option Fund. No financial terms were disclosed. SolMap is a biotech venture that uses computational and experimental fragment-based drug design.
1 October 2008•2 mins read
